Causeway Capital Management’s Merck MRK Stock Holding History

Causeway Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$123M	Buy	954,932 +100,720	+12%	+$11.8M	1.33%	10
2026 Q1	$103M	Sell	854,212 -190,405	-18%	-$22M	1.26%	9
2025 Q4	$110M	Sell	1,044,617 -89,440	-8%	-$8.4M	1.51%	10
2025 Q3	$95.2M	Buy	1,134,057 +151,397	+15%	+$12.5M	1.26%	12
2025 Q2	$77.8M	Buy	982,660 +84,791	+9%	+$6.74M	1.23%	13
2025 Q1	$80.6M	Buy	897,869 +313,396	+54%	+$29.3M	1.68%	12
2024 Q4	$58.1M	Buy	+584,473	New	+$60.3M	1.32%	19
2020 Q3	–	Sell	-853,150	Closed	-$63M	–	85
2020 Q2	$63M	Sell	853,150 -671,734	-44%	-$50.6M	1.13%	24
2020 Q1	$112M	Sell	1,524,884 -330,191	-18%	-$26M	1.79%	17
2019 Q4	$161M	Sell	1,855,075 -62,330	-3%	-$5.12M	1.73%	19
2019 Q3	$154M	Buy	1,917,405 +72,867	+4%	+$5.84M	1.84%	20
2019 Q2	$148M	Buy	1,844,538 +17,906	+1%	+$1.37M	1.62%	21
2019 Q1	$145M	Buy	+1,826,632	New	+$137M	1.46%	19

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Causeway Capital Management's MRK Position: Q2 2026 in Review

Causeway Capital Management increased its Merck (MRK) stake by 12% in Q2 2026, buying an estimated $11.8M and bringing the position to 954,932 shares worth $123M. The position accounts for 1.33% of the portfolio, ranked #10.

Causeway Capital Management first reported a position in MRK in Q1 2019 and has held it in 13 quarters since. The position peaked at $161M in Q4 2019. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Causeway Capital Management held 954,932 shares of Merck worth $123M as of Q2 2026.
Causeway Capital Management bought 100,720 Merck shares in Q2 2026, an estimated $11.8M.
Merck made up 1.33% of Causeway Capital Management's portfolio in Q2 2026, its #10 holding.
Causeway Capital Management first reported a position in Merck in Q1 2019 and has held it in 13 quarters since.
Causeway Capital Management's Merck position peaked at $161M in Q4 2019.
3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Causeway Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.